The Health Impact of High Intensity Exercise Training With Intervals During Cardiac Rehabilitation

A Randomised Controlled Trial on the Efficacy of High Intensity Interval Training Compared With Moderate Intensity Interval Training for Patients Undergoing Cardiac Rehabilitation

Cardiac rehabilitation is a program designed to help patients regain good health through lifestyle change after a heart attack, heart surgery or other heart problems. Patients will take part in exercise sessions and education lessons, tailored to meet their personal needs. The exercise training component of cardiac rehabilitation may be delivered as intervals of short intense sessions (also known as high intensity intervals) or the current standard care of longer but less intense sessions (moderate intense intervals). Both exercises have been shown to increase fitness levels and also prevent future risk of heart disease.

The purpose of this study is to determine the efficacy and safety of high intensity interval exercise training (HIIT) in patients who had a recent cardiac revascularization procedure or recovering from a heart attack, in comparison to current standard of moderate intensity exercise training in terms of their physical fitness and psychological well-being.

Study Overview

Detailed Description

Cardiac rehabilitation is an eight week program designed to help patients regain good health through changed lifestyle after a possible heart attack, heart surgery or other heart problems. Patients will take part in exercise sessions and education lessons, tailored to meet their personal needs. The exercise training component of cardiac rehabilitation may be delivered as intervals of short intense sessions (also known as high intensity intervals) or the current standard care of longer but less intense sessions (moderate intense intervals). Both exercises have been shown to increase fitness levels and also prevent future risk of heart disease. Although there is some evidence to suggest that high intensity interval training produces better body muscles recovery and fitness during cardiac rehabilitation, many important health outcomes have not yet been determined. Such outcomes include the ability of the body to safely control blood pressure and heartbeat rate. Others include health-related quality of life and emotional well-being.

This study will explore whether there are any differences in health outcomes before and after the introduction of the intervention for patients undergoing high intensity interval exercise compared to those on moderate intensity interval exercise in terms of the recovery of the ability to control blood pressure and heartbeat rate, and also health-related quality of life and emotional well-being. In addition, patients' opinions will be sought regarding pain levels, the acceptability and the extent of enjoyment they get from each of the two types of exercise training.

For each patient, their exercise program will be designed to match their preferences and requirements. Some may prefer to work in a gym environment and so will have their program designed around this type of activity. Others may prefer to work in a group exercise circuit, with their program matched to what is available. When comparing the two types of exercise, everything will be kept the same; from the warm up and cool down, to the types of movements; the only thing that will change is the intensity of the exercise.

Before and after the eight week training program, patients will be asked to have an assessment to measure the effects that the exercise has on their body. Things like heart rate and blood pressure will be taken and they will also undergo a physical fitness test.

After the training, patients will complete questionnaires to establish their level of enjoyment of the program, how motivated they were to complete it. In addition, their quality of life and emotional well-being will be measured by completing questionnaires before and after the 8 weeks of the cardiac rehabilitation program. The investigators anticipate that a total of 46 patients will be recruited for the study over a period of 6 months. In the United Kingdom, it is believed that delivering an improved exercise training program has the potential to enhance patients' recovery from heart disease that may reduce the need for hospital services and therefore a better use of the National Health Service resources.

Study Type

Interventional

Enrollment (Actual)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Liverpool, United Kingdom, L14 3PE
        • Liverpool Heart and Chest Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • History of acute coronary syndromes, had a recent revascularization procedure
  • History of stable heart failure or stable angina.

Exclusion Criteria:

  • Unstable angina
  • Systolic blood pressure of >200 mm Hg, or diastolic blood pressure >110 mm Hg (should be assessed on a case-by-case basis)
  • Orthostatic blood pressure drop of >20 mm Hg with symptoms
  • May have had the implantation of cardiac defibrillators (ICD)
  • Synchronization devices or ventricular assist devices
  • Have had a heart valve repair/replacement, a heart transplant, or grown-up congenital heart disease, critical aortic stenosis, acute systemic illness or fever, -
  • Uncontrolled atrial or ventricular arrhythmias, acute pericarditis or myocarditis
  • Recent embolism, thrombophlebitis, resting S-T segment depression (>2 mm), uncontrolled diabetes (should be assessed in accordance with local protocol and on a case-by-case basis)
  • Severe orthopedic conditions that would prohibit exercise
  • Other metabolic conditions, such as acute thyroiditis, hypokalemia or hyperkalemia, hypovolemia, severe rejection (cardiac transplant recipients), triple A >4.5 cm (if under surveillance will need confirmation from vascular surgeon as long as blood pressure remains stable)
  • Tachycardia >100 beats per minute at rest, or cataracts (may commence exercise after 6 weeks)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High intensity interval training (HIIT)

Patients will undergo a 15-minute warm-up, followed by a 24-minute conditioning phase, and a 10-minute cool-down. The conditioning phase will include a combination of aerobic exercise (e.g. cycling or walking) and resistance exercise (e.g. squats, bicep curls). Patients will complete 5 intervals of 3 minutes with 2 minute rest periods interspersed. The intensity will correspond to 16-17 on the Borg 6-20 Rating of perceived exertion scale.

Patients will exercise once a week for 8 weeks.

Standard care cardiac rehabilitation classes, delivered at a higher exercise intensity
Other Names:
  • Group 1
Active Comparator: Standard Care

Patients assigned to this group will participate in usual standard care of cardiac rehabilitation.

Commonly, patients will undergo a 15-minute warm-up, followed by a 24-minute conditioning phase, and a 10-minute cool-down. The conditioning phase will include a combination of aerobic exercise (e.g. cycling or walking) and resistance exercise (e.g. squats, bicep curls). Patients will complete 5 intervals of 3 minutes with 2 minute rest periods interspersed. The intensity will correspond to 11-15 on the Borg 6-20 Rating of perceived exertion scale.

Patients will exercise once a week for 8 weeks.

Standard care cardiac rehabilitation according to current guidelines
Other Names:
  • Group 2

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Heart Rate Variability (as measured by a hemodynamic monitoring system)
Time Frame: Change from baseline in heart rate variability at 8 weeks after the start of the intervention
The primary outcome is the difference in heart rate variability between baseline and 8 weeks after the start of the intervention measured using finger photoplethysmography
Change from baseline in heart rate variability at 8 weeks after the start of the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Baroreflex Sensitivity (as measured by a hemodynamic monitoring system)
Time Frame: Change from baseline in baroreflex sensitivity at 8 weeks after the start of the intervention
This is the difference in heart rate variability between baseline and 8 weeks after the start of intervention measured using finger photoplethysmography
Change from baseline in baroreflex sensitivity at 8 weeks after the start of the intervention
Changes in Peak Oxygen Uptake (as measured by a submaximal exercise test)
Time Frame: Changes in peak oxygen uptake between baseline and 8 weeks after the start of intervention
Submaximal Cardiopulmonary Exercise Testing will be performed to measure changes in peak oxygen uptake between baseline and 8 weeks after the start of the intervention
Changes in peak oxygen uptake between baseline and 8 weeks after the start of intervention
Changes in Enjoyment of Exercise (as measured by a questionnaire)
Time Frame: Changes in perception of enjoyment of exercise at between baseline and 8 weeks after the start of intervention
Changes in pleasure and displeasure, affect, arousal between baseline and 8 weeks after the start of intervention will be assessed by using a "Feelings Scale", "Felt Arousal Scale", "Physical Activity Enjoyment Scale" respectively.
Changes in perception of enjoyment of exercise at between baseline and 8 weeks after the start of intervention
Changes in health-related Quality of Life (as measured by a questionnaire)
Time Frame: Changes in health-related quality of life between baseline and 8 weeks after the start of intervention
Changes in health-related quality of life between baseline and 8 weeks after the start of intervention will be measured by completion of MacNew Quality of Life questionnaires
Changes in health-related quality of life between baseline and 8 weeks after the start of intervention
Changes in Rating of Perceived Exertion (as measured by a scale)
Time Frame: Changes in the rating of perceived exertion between baseline and 8 weeks after start of intervention
Ratings of perceived exertion (RPE) allow the intensity of exercise to be determined subjectively on a scale of 6-20. Changes in RPE scales will be assessed at start of each workout as part of service protocol to gauge patient effort, fatigue and muscular discomfort and the differences between baseline and 8 weeks after start of intervention will be determined. At the end of each session, patients will be expected to submit an overall session RPE of how they perceived the entire exercise session (Kilpatrick et al. 2014).
Changes in the rating of perceived exertion between baseline and 8 weeks after start of intervention

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in reported incidents of acute pain (as measured by a visual analogue scale)
Time Frame: Changes between baseline incidents of acute pain and 8 weeks after start of intervention
Pain is a contributing factor to the displeasure experienced during some exercise (Ekkekakis et al. 2012). For this reason participants will be required to complete a visual analogue scale to quantify any pain during the sessions. Changes in perception of pain will assessed between baseline and 8 weeks after the start of intervention.
Changes between baseline incidents of acute pain and 8 weeks after start of intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Alison C Welsh, Edge Hill University and Liverpool Heart and Chest Hospital
  • Principal Investigator: Adrian Roose, Liverpool Heart and Chest Hospital
  • Principal Investigator: Joseph Mills, Liverpool Heart and Chest Hospital
  • Principal Investigator: Bashir Matata, Liverpool Heart and Chest Hospital
  • Principal Investigator: Adrian Midgley, Edge Hill University
  • Principal Investigator: Felipe Cunha, Edge Hill University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2015

Primary Completion (Actual)

March 1, 2016

Study Completion (Actual)

June 1, 2016

Study Registration Dates

First Submitted

February 11, 2015

First Submitted That Met QC Criteria

February 25, 2015

First Posted (Estimate)

March 3, 2015

Study Record Updates

Last Update Posted (Estimate)

August 18, 2016

Last Update Submitted That Met QC Criteria

August 17, 2016

Last Verified

August 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Disease

Clinical Trials on High intensity interval training (HIIT)

Subscribe